Innoviva (INVA) Return on Sales (2011 - 2026)

Innoviva's (INVA) quarterly Return on Sales came in at 0.02% in Q1 2026, up 2.0% YoY from 0.02% in Q1 2025, and up 112.09% on a QoQ basis from 0.16% in Q4 2025.

Innoviva (INVA) Return on Sales (2011 - 2026) Analysis & Trends

Innoviva (INVA) has 16 years of Return on Sales data on file, last reported at 0.02% in Q1 2026.

  • Quarterly Return on Sales rose 2.0% year-over-year to 0.02% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (up 1.0% YoY) and the FY2025 annual result came in at 0.01%, up 1.0% from the prior year.
  • Return on Sales climbed to 0.02% in Q1 2026, from 0.16% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.19% in Q1 2023 to a low of 1.6% in Q4 2024.
  • A 5-year average of 0.08% and a median of 0.0% in 2023 frame the typical range for Return on Sales.
  • Annual changes were most pronounced in 2024 — Return on Sales slumped 154 bps — and 2025, when it soared 145 bps.
  • Tracing INVA's Return on Sales over 5 years: stood at 0.15% in 2022, then jumped by 56 bps to 0.07% in 2023, then slumped by 2309 bps to 1.6% in 2024, then soared by 90 bps to 0.16% in 2025, then soared by 112 bps to 0.02% in 2026.
  • The last three Return on Sales figures came in at 0.02% (Q1 2026), 0.16% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 0.00%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.00%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 0.00%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.00%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.00%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 0.00%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 0.00%
10 Innoviva 1.54 Bn 968.79 Mn 90.62 Mn -0.01%

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.01%
Mar 31, 2026 0.02%
Dec 31, 2025 -0.16%
Sep 30, 2025 0.00%
Jun 30, 2025 0.01%
Mar 31, 2025 -0.01%
Dec 31, 2024 -1.60%
Sep 30, 2024 0.00%
Jun 30, 2024 0.00%
Mar 31, 2024 0.15%
Dec 31, 2023 -0.07%
Sep 30, 2023 0.01%
Jun 30, 2023 0.00%
Mar 31, 2023 0.19%
Dec 31, 2022 -0.15%
Sep 30, 2022 0.01%
Jun 30, 2022 0.05%
Mar 31, 2022 0.17%
Dec 31, 2021 -0.45%
Sep 30, 2021 0.01%